Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$58,724,342
+$29,605,296 QoQ
Shares Held
1,224,955
+54.6% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#51
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cullen Capital Management, LLC holds $1,067,869,600 across 8 Drug Manufacturers - General names. NVO ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
2,033,040 | $318,618,028 | |
| 2 | JNJ |
Johnson & Johnson
|
1,099,077 | $279,132,585 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,016,795 | $259,158,157 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,132,367 | $65,246,986 | |
| 5 | PFE |
Pfizer Inc
|
2,447,200 | $58,928,576 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
1,224,955 | $58,724,342 | |
| 7 | SNY |
Sanofi
|
615,593 | $26,261,197 | |
| 8 | ABBV |
AbbVie Inc.
|
7,152 | $1,799,729 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,724,342 | 1,224,955 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $29,119,046 | 792,355 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,857,817 | 547,520 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||